| Julia L Torres, | |
|
416 N Avenue C4, Cheyenne, WY 82007-2506 | |
| (307) 214-7592 | |
| Not Available |
| Full Name | Julia L Torres |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 416 N Avenue C4, Cheyenne, Wyoming |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174015473 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 518 (Wyoming) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Julia L Torres, 1407 W 32nd St, Cheyenne, WY 82001-7216 Ph: (307) 214-7592 | Julia L Torres, 416 N Avenue C4, Cheyenne, WY 82007-2506 Ph: (307) 214-7592 |
News Archive
Discovery of a dual role played by the enzyme phosphoglycerate kinase 1 (PGK1) may indicate a new therapeutic target for glioblastoma, an often fatal form of brain cancer, according to researchers at The University of Texas MD Anderson Cancer Center.
Genervon Biopharmaceuticals announced today that the U.S. Food and Drug Administration has granted an "orphan drug" designation to Genervon's GM604 (a.k.a. GM6) bio-drug for the treatment of Amyotrophic Lateral Sclerosis (ALS). The FDA also granted GM604 a "fast-track" designation for ALS in 2013.
Medical errors are estimated to cause 250,000 deaths per year in the US. Previously, research on admitted patients suggested that errors are due to the way doctors process the data they have about patients - in other words, doctors have the right information, but might not act on it in the best way.
Taligen Therapeutics, a biotechnology company developing therapies that regulate the complement system to treat inflammatory and immune diseases, today announced that preclinical data on three of its pipeline candidates will be highlighted at the XXIII International Complement Workshop taking place August 1-5, 2010, in New York City.
Ascletis announced today the completion of a US$35 million (RMB 220 million) financing. The investment was led by C-Bridge Capital, joined by Tasly Pharmaceutical and Singapore-based Pavilion Capital. The valuation of the Company before financing was US$300 million.
› Verified 3 days ago
Gregory Stelzner, MSW, LCSW-950 Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 2909 Bent Ave, Cheyenne, WY 82001 Phone: 307-772-1142 | |
Chelsea Hampton, MSW PCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 604 E 25th St, Cheyenne, WY 82001 Phone: 307-637-3953 | |
Nolan Marie Vitzthum, MSW, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 4025 Rawlins St, Cheyenne, WY 82001 Phone: 307-426-4797 | |
Corinne Lea Hogg, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 2360 E Pershing Blvd, Cheyenne, WY 82001 Phone: 307-757-8583 | |
Alyssa Nicole Bjorkquist, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1807 Capitol Ave Ste 109, Cheyenne, WY 82001 Phone: 307-256-6467 | |
Mr. William David Anderson, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2360 E Pershing Blvd, Cheyenne, WY 82001 Phone: 307-778-7550 Fax: 307-778-7599 | |
Richard A Esquibel, BSW, CSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 604 E 25th St, Cheyenne, WY 82001 Phone: 307-637-3953 Fax: 307-638-6805 |